Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease
Huma Therapeutics, a leading global digital health company, today announced a partnership with Camden Health […]
Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth
Spectrum Science, an independent, integrated marketing, communications and media firm focused on the pharmaceutical, biotech […]
Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute
Actinium Pharmaceuticals, a leader in the development of targeted radiotherapies, have announced that it has […]
Ultima Genomics and Integrated DNA Technologies to Enable Application Portfolio on Ultima Sequencing Platforms
Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, has announced a […]
Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform
As part of a shared commitment to bring better solutions for people suffering from depression, […]
Chong Kun Dang Pharm and Synaffix Enter a Licensing Agreement
Chong Kun Dang Pharm (CKD), a global pharmaceutical company based in South Korea, and Synaffix […]
iCRYO Announces Partnership with Therapeutic Manufacturer, BTL
iCRYO, the fast-growing recovery and wellness brand that focuses on a series of health-related recovery […]
Digital Diagnostics and Tamer Healthcare Announce Strategic Partnership in the Kingdom of Saudi Arabia
Digital Diagnostics, maker of IDx-DR, the first-ever FDA-cleared, fully autonomous AI system for the diagnosis […]
20Med Therapeutics and CEPI Sign Agreement to Advance ThermoStable Vaccines Technology
20Med Therapeutics, a leader in non-viral delivery of genetic vaccines using polymeric nanoparticles, and CEPI, […]
Orbit Discovery and Endevica Bio Enter Multi-target Collaboration to Advance Development of Cachexia Therapeutics
Orbit Discovery, a leader in the discovery of therapeutic peptide hits, today announced it has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more